Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Cardiothoracic Surgery|June 6, 2022
Thoracoscopic resection of posterior mediastinal paraganglioma: perioperative management and surgical tipsYuki Matsumura, Mitsuro Fukuhara, Hayato Tanabe, et al.
Thoracic Cancer|September 5, 2022
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case reportMasayuki Watanabe, Yuki Matsumura, Hikaru Yamaguchi, et al.
Journal of Medical Case Reports|October 25, 2019
Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literatureTakeo Hasegawa, Yuki Ozaki, Takuya Inoue, et al.
Interactive Cardiovascular and Thoracic Surgery|October 20, 2017
Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinomaYuki Matsumura, Yuki Owada, Takuya Inoue, et al.
Thoracic Cancer|June 23, 2021
A patient with ALK-positive lung adenocarcinoma who survived alectinib-refractory postoperative recurrence for 4 years by switching to ceritinibYuki Matsumura, Sho Inomata, Hikaru Yamaguchi, et al.
International Journal of Oncology|October 14, 2015
Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancerSatoshi Muto, Yuki Owada, Takuya Inoue, et al.
Cancer Reports (Hoboken, N.J.)|October 5, 2022
Ectopic adrenocorticotropic hormone-secreting carcinoid with solitary cryptococcosis in the lungsHironori Takagi, Yuki Matsumura, Mitsuro Fukuhara, et al.
Anticancer Research|May 29, 2017
Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer PatientsSatoshi Muto, Hironori Takagi, Yuki Owada, et al.
Fukushima Journal of Medical Science|February 21, 2018
Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancerMitsunori Higuchi, Hironori Takagi, Yuki Ozaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 22, 2023
[Clinical Features of Endocrine Disorders with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer]Hironori Takagi, Satoshi Muto, Mitsuro Fukuhara, et al.
Pageof 4